EGFR mutations are the most common type of mutation in lung adenocarcinoma (LUAD), and the therapeutic strategies and prognoses of patients have been greatly improved with advances in EGFR-TKIs [3]. The gene discussed is EGFR; the disease is lung adenocarcinoma.